Ricerc@Sapienza

The risk of developing a second malignant cancer as a late time consequence of undergoing a treatment, is one of the main concerns in particle therapy (PT). Since neutrons can release a significant dose far away from the tumour region, a precise characterisation of their production point, kinetic energy and abundance is eagerly needed. The treatment planning system (TPS) software that predicts the normal tissue toxicity in the target region and the risk of late complications in the whole body is currently based on the poorly known production cross-sections and will greatly benefit from improved precision double differential measurements. The MONDO (MOnitor for Neutron Dose in hadrOntherapy) project aims to build an ultrafast neutron tracker that could be used to characterise the production of secondary neutrons with energies in the 20-400 MeV range. The neutron tracking will proceed via the detection of recoil protons produced in two consecutive (n, p) elastic scattering interactions. The MONDO detector consists of a 10 × 10 × 20 cm3matrix of thin scintillating fibres, arranged in orthogonally oriented layers. A compact read-out sensor with single photon detection capabilities employing the CMOS SPAD technology has been developed in collaboration with Fondazione Bruno Kessler (FBK). The detector will be completed by the end of 2018. A 4 × 4 × 4.8 cm3prototype has been built using 250 μ m thick scintillating fibres of squared section and was tested using a proton beam and minimum ionising particles. In this contribution we present the experimental results related to the prototype test performed with a proton beam at the Proton Therapy Centre of the Trento Hospital (PTC) in May 2017. The results are compared with the results of a Monte Carlo simulation performed with the FLUKA software.